Skip to main content
. 2017 May-Jun;33(3):534–539. doi: 10.12669/pjms.333.12395

Table-IV.

Demographic and laboratory results of the patients who died.

Parameter Patient 1 Patient 2 Patient 3
Age 62 51 67
Sex Female Male Male
Method Suicide Suicide Accidental
Agent Diazinon Diazinon Diazinon
Comorbidity HT, DM, Obesity HT, DM, Obesity, CAD HT, DM, CAD
Initial PChE 0,1KU/L <0.1KU/L <0.1KU/L
PChE at 48th hour 0.1KU/L <0.1KU/L <0.1KU/L
Respiratory situation Delayed admittance at 12th hour of ingestion, Immediate Intubation and MV support Intubation at 24th hour, MV support, Intermediate Syndrome Intubation at 3rd day, MV support, Intermediate Syndrome
Number of MV days 17 7 92
Hospitalization time Exitus at 17th day Exitus at 8th day Exitus at 95th day
Complications Non-STMI, Pulmonary Thromboembolism Non-STMI, Atrial Fibrillation Non-STMI, UGIB, Ventilator-Related Pneumonia, Septic Shock

Abbreviations: CAD: Coronary Arterial Disease; DM: Diabetes Mellitus; HT: Hypertension; MV: Mechanical Ventilation; Non-STMI: Non ST elevation myocardial infarction; PChE: Pseudocholinesterase; UGIB: Upper gastrointestinal bleeding.